Plasmin triggers cytokine induction in human monocyte-derived macrophages

Qun Li1, Yves Laumonnier, Tatiana Syrovets

  • 1Institute of Pharmacology of Natural Products and Clinical Pharmacology, University of Ulm, Helmholtzstr. 20, D-89081 Ulm, Germany.

Abstract

Insights

Plasmin activates macrophages by binding to the annexin A2 heterotetramer, initiating signaling pathways that induce pro-inflammatory cytokine production, crucial for understanding inflammation in conditions like atherosclerosis.

Area of Science:

  • Immunology
  • Vascular Biology
  • Molecular Medicine

Background:

  • Fibrinolytic activity, involving plasmin, is elevated in atherosclerotic lesions.
  • The specific role of plasmin in macrophage function within these lesions remains largely unexplored.

Purpose of the Study:

  • To investigate the direct impact of plasmin on human monocyte-derived macrophages.
  • To elucidate the molecular mechanisms underlying plasmin-mediated macrophage activation.

Main Methods:

  • Utilized human monocyte-derived macrophages.
  • Investigated signaling pathways including JAK/STAT, Akt/NF-kappaB, and MAPK.
  • Employed inhibitors and antisense oligodeoxynucleotides to probe pathway dependency.

Main Results:

  • Plasmin activates macrophages via the annexin A2 heterotetramer (annexin A2/S100A10).
  • This activation triggers JAK1/TYK2, STAT3, NF-kappaB, ERK1/2, and p38 signaling.
  • Plasmin-induced cytokine (TNF-α, IL-6) expression is dependent on annexin A2 heterotetramer and specific signaling pathways.

Conclusions:

  • Plasmin generated at inflammatory sites, such as atherosclerotic lesions, stimulates cytokine expression in human macrophages.
  • This highlights a novel role for plasmin in modulating the inflammatory response within atherosclerosis.